Discover
GUTS
Fractyl Health, Inc.
0.78
1 x 0.77
2 x 1.03
bid
ask
-
0.01
1.50%
2 @ 04:00 PM
0.80 +0.02 (2.24%)
| Ytd | -64.43% | |
| 1y | -50.47% |
0.78
day range
0.83
0.38
52 week range
2.44
| Open | 0.83 | Prev Close | 0.79 | Low | 0.78 | High | 0.83 | Mkt Cap | 124.14M |
| Vol | 1.04M | Avg Vol | 1.86M | EPS | -1.31 | P/E | N/A | Forward P/E | -0.77 |
| Beta | N/A | Short Ratio | 5.48 | Inst. Own | 86.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.77 | 200-d Avg | 1.09 | 1yr Est | 15.50 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | -0.5 | -0.48 | 0.02 | 4.00% |
| 2024-08-14 | 2024-06 | -0.46 | N/A | N/A | N/A |
| 2024-08-14 | 2024-06 | -0.46 | -0.36 | 0.1 | 21.74% |
| 2024-05-13 | 2024-03 | -0.3 | N/A | N/A | N/A |
| 2024-05-13 | 2024-03 | -0.3 | -0.75 | -0.45 | -150.00% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-02-28 | Evercore ISI Group | Upgrade | Outperform | |
| 2024-02-27 | Morgan Stanley | Upgrade | Overweight |
Profile
Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-02-05 | AMERICAN HOME ASSURANCE CO | Beneficial Owner of more than 10% of a Class of Security | 283.88K | Conversion of Exercise of derivative security |
| 2024-02-05 | AMERICAN INTERNATIONAL GROUP, INC | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Conversion of Exercise of derivative security |
| 2024-11-10 | CAPLAN JAY DAVID | President | 631.16K | Sale |
| 2024-02-05 | CVF LLC | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
| 2024-02-05 | ELIA MARC | Director | 0.00 | Purchase |
| 2024-02-05 | FLYNN JAMES E | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Conversion of Exercise of derivative security |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Deer Management Co. LLC | 4.77M | 9.06M | 9.92% |
| 2024-09-29 | Hcc Manager LLC | 4.67M | 8.88M | 9.72% |
| 2024-09-29 | Maverick Capital Ltd. | 4.25M | 8.07M | 8.83% |
| 2024-09-29 | Blackrock Inc. | 2.23M | 4.24M | 4.64% |
| 2024-09-29 | M28 Capital Management LP | 1.86M | 3.53M | 3.86% |
| 2024-09-29 | Ensign Peak Advisors, Inc | 1.41M | 2.68M | 2.93% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-10-30 | iShares Russell 2000 ETF | 646.82K | 1.23M | 1.34% |
| 2024-08-30 | MFS New Discovery Fund | 639.15K | 1.21M | 1.33% |
| 2024-09-29 | MFS Variable Insurance Trust-MFS New Discovery Series | 195.10K | 370.70K | 0.41% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 194.80K | 370.11K | 0.40% |
| 2024-10-30 | iShares Russell 2000 Growth ETF | 171.37K | 325.60K | 0.36% |
| 2024-09-29 | Pacific Select Fund-Small Cap Growth Portfolio | 143.20K | 272.08K | 0.30% |